| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati | ||
| Fr | European STI cases reach record high amid testing and prevention gaps | ||
| Fr | Gilead Sciences acquires Tubulis for $5bn | ||
| Fr | Concept Life Sciences and OpenBench partner on drug discovery services | ||
| Do | Gilead teams up with WHO again to eliminate parasitic tropical disease | ||
| Do | Eli Lilly maintains M&A streak with $202m Engage Bio buyout | ||
| Do | FUJIFILM opens new iPSC facility in Madison, US | ||
| Do | BMS and Anthropic collaborate for Claude implementation | ||
| Mi | Investment giants join forces to form largest healthcare firm on the globe | ||
| Mi | Clinical Trials Day 2026: 'Research Rising' theme reflected in Q1 study growth | ||
| Mi | Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict | ||
| Mi | QIAGEN and NVIDIA partner on AI drug discovery | ||
| Mi | SERB signs agreement to acquire Idefirix rights for $133.6m | ||
| Di | UK government bolsters antiviral supply for hantavirus | ||
| Di | VERTANICAL's VER-01 gains FDA breakthrough status for low back pain | ||
| Di | Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates | ||
| Mo | Vaccine void means current Ebola outbreak declared international emergency | ||
| Mo | Tracy Beth Høeg ousted from FDA in wider senior leadership shakeup | ||
| Mo | Japan's MHLW approves Boehringer's Jascayd for IPF and PPF | ||
| Mo | FDA approves Enhertu for two HER2-positive early breast cancer indications | ||
| 15.05. | Nonprofits join forces to debut marketplace for shelved CGTs | ||
| 15.05. | Arna Pharma and Slate Run complete JV for new US company | ||
| 15.05. | Biopharma industry endorses Pazdur for FDA commissioner role | ||
| 15.05. | Kyowa Kirin secures FDA approval for Crysvita dosing update | ||
| 14.05. | UK health secretary Wes Streeting resigns |